Study of KITE-197 in Participants With Relapsed or Refractory Large B-cell Lymphoma
Clinical trial NCT06079164 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06079164
- Sponsor
- Kite, A Gilead Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-09
- Primary completion
- 2026-07-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.